Secretary Fang Wenbang and his party investigated the Hualian Mede Clinical Medical Experimental Center, a subsidiary of the group

Communicate cordially with the doctors of the Science and Technology City Hospital who carried out animal experiments on the spot

Secretary Fang first came to the clinical medical laboratory covering an area of 300 square meters. And have a cordial exchange with the doctors of the Science and Technology City Hospital who are carrying out animal experiments on the spot. The laboratory can simultaneously perform 4 minimally invasive surgical operations based on large experimental animals. The doctors said that the establishment of the first third-party public animal experiment platform in the high-tech zone provides a more favorable environment for clinicians to improve surgical skills, carry out surgical innovation, and promote innovative activities in the integration of medicine and industry.

Listen to the report on the development of the center

Subsequently, Secretary Fang listened to a report on the development of Hualian Virtue. When I heard that before the outbreak of the new crown epidemic in 2019, several Wuhan medical teams were practicing lung transplant surgery techniques at Hualian Virtue, I was very relieved. Upon learning that Hualian Meide Phase II planned to invest 10 million yuan to build an endoscopic surgery center and catheterization laboratory, Secretary Fang spoke highly of the company's efforts to overcome difficulties and actively provide supporting services for the medical device industry in the high-tech zone. And send a message to Hualian Virtue to stand up to the forefront and make more contributions to the development of the medical device industry in the high-tech zone.

Mr. Weng Zhiqiang, Chairman of the Group, Ms. Zhang Ping, Chief Financial Officer, and Mr. Gu Yifei, General Manager of Hualian Mede participated in the survey activities.